Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Point of care testing for human chorionic gonadotropin, creatinine, and blood urea nitrogen: cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2013 Authors' conclusions One economic evaluation was identified regarding the cost-effectiveness of point of care testing for creatinine; no literature was identified regarding the cost-effectiveness of point of care testing for human chorionic gonadotropin or blood urea nitrogen. Indexing Status Subject indexing assigned by CRD MeSH Blood Urea Nitrogen; Chorionic Gonadotropin; Creatinine; Humans; Point-of-Care Systems Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32014000136 Date abstract record published 24/01/2014 |